Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.7 |
mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |